NEW YORK (GenomeWeb) - Chembio Diagnostic Systems announced today that it has received a $550,000 grant from the Paul G. Allen Family Foundation to develop point-of-care diagnostics for the Zika virus.

Medford, New York-based Chembio will use the grant to develop a Zika-specific assay for  its Dual Path Platform (DPP) technology, as well as a multiplex assay to detect the Zika, Dengue, and Chikungunya viruses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

Sponsored by

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms.